F. Ozdener, V. Ozdemir
Sep 1, 2003
Citations
0
Influential Citations
1
Citations
Journal
Current opinion in investigational drugs
Abstract
Lilly is developing fasidotril, a diester prodrug of the active metabolite fasidotrilat, for the potential treatment of hypertension and congestive heart failure (CHF). Phase II trials to investigate the potential of fasidotril for the treatment of hypertension and CHF had commenced by the late 1990s, and were ongoing in July 2003 in the US and Europe.